
Hepion (HEPA) Stock Is Surging Before A Trial Data Review
Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is experiencing a notable uptrend today, marking a 14.95% surge during the morning session, with its stock value reaching $3.3450.
Home » Hepion stock
Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is experiencing a notable uptrend today, marking a 14.95% surge during the morning session, with its stock value reaching $3.3450.
On February 18, American stock indices ended in the red. The S&P 500 index fell 0.44% to 3914 points, the Dow Jones fell 0.38%, the
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will
AnPac Bio-Medical Science Co. Ltd. (ANPC) stock plunged 0.0% to $7.14 in the pre-market trading after announcing that it experienced strong demand for its cancer
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.